Pharmaceuticals

Drug Development Stock Market Market Trends Pharmaceuticals Investments Clinical Trials Regulatory Affairs Public Health Drug Development Biotechnology

Gilead Poised to Secure U.S. Approval for Biannual HIV Prevention Shot

Gilead aims to supply generic versions in 120 low-income countries under agreements that exclude Brazil, Argentina and parts of Eastern Europe.

Eli Lilly to Acquire Verve Therapeutics for $1.3 Billion

AstraZeneca Deepens China Pact With $5.2 Billion CSPC Research Collaboration

FDA Expands Moderna RSV Vaccine to Adults 18–59 at Risk

Bristol Myers Squibb and BioNTech partner on $11 billion bispecific antibody cancer drug

Sanofi to Acquire Blueprint Medicines for $9.1 Billion, Boosting Its Rare Immunology Pipeline

Trump Administration Begins Enforcing Prescription Drug Price Controls

Moderna Withdraws Flu-COVID Vaccine Application After FDA Requests More Data

Gland Pharma Q4 FY25 Results Miss Estimates as US Revenue Declines

Zydus Lifesciences Posts Robust Q4 FY25 Results as Analysts Debate Future Risks

Pfizer Secures $6 Billion Licensing Deal for Chinese Cancer Drug SSGJ-707

UK Finalizes £1bn BioNTech Deal to Advance mRNA Cancer Vaccines and AI Research

FDA Grants Limited Approval to Novavax’s COVID-19 Vaccine

Novo Nordisk CEO Steps Down Following Share Price Collapse

Sanofi Announces $20 Billion U.S. Investment to Expand Manufacturing and R&D

Rep. Ro Khanna Files Legislation to Codify Trump’s Drug Pricing Executive Order

EU Court Overturns Commission's Refusal to Release von der Leyen-Pfizer Texts

UP CM Yogi Adityanath Declares Food Adulteration a Social Crime, Intensifies Crackdown

GSK Acquires Experimental Liver Drug Efimosfermin for $1.2 Billion Upfront

Novo Nordisk Partners with Septerna in $2.2 Billion Deal for Oral Obesity Therapies